Word

ADAC

Status

Registered

Status Code

700

Status Date

Tuesday, February 7, 2023

Serial Number

79322105

Registration Number

6970291

Registration Date

Tuesday, February 7, 2023

Mark Type

4000

Filing Date

Tuesday, August 24, 2021

Published for Opposition

Tuesday, November 22, 2022

Trademark Owner History

Strike Pharma AB - Original Registrant

Classifications

5 Pharmaceutical preparations for human use for the treatment and prevention of diseases and conditions in the areas of immunology, oncology, immune-oncology, diabetes, autoimmunology, dermatology, gynecology, urology, gastroenterology and ophthalmology; veterinary preparations for the treatment and prevention of diseases and conditions in the areas of immunology, oncology, immune-oncology, diabetes, autoimmunology, dermatology, gynecology, urology, gastroenterology and ophthalmology; vaccines; therapeutic medicines for the treatment and prevention of diseases and conditions in the areas of immunology, oncology, immune-oncology, diabetes, autoimmunology, dermatology, gynecology, urology, gastroenterology and ophthalmology; pharmaceutical preparations for the treatment of diseases and conditions in the areas of immunology, oncology, immuno-oncology, diabetes, autoimmunology, dermatology, gynecology, urology, gastroenterology and ophthalmology; therapeutic antibodies for the treatment and prevention of diseases and conditions in the areas of immunology, oncology, immune-oncology, diabetes, autoimmunology, dermatology, gynecology, urology, gastroenterology and ophthalmology

1 Chemicals for use in industry for production of antibodies and synthetic and natural peptides

10 Delivery systems in the nature of implantable drug delivery ports for the deferred, controlled or immediate release of active substances of pharmaceutical preparations; inhalers for medical use; syringes for injection and medical purposes

42 Research and development within the biological, pharmacological, veterinary, microbiological, biomedical, pharmabiotical, biotherapeutical and biotechnological areas; research and development of new products featuring a synthetic antibody library including methods for selection and screening of such; research and development in the area of personalized medicine; medical laboratory services related to production of antibodies; research and development in the area of antibodies

Trademark Events

May 30, 2023

Final Decision Transaction Processed By Ib

May 8, 2023

Final Disposition Notice Sent To Ib

May 8, 2023

Final Disposition Processed

May 7, 2023

Final Disposition Notice Created, To Be Sent To Ib

Feb 7, 2023

Notice Of Registration Confirmation Emailed

Feb 7, 2023

Registered-Principal Register

Nov 22, 2022

Official Gazette Publication Confirmation E-Mailed

Nov 22, 2022

Published For Opposition

Nov 2, 2022

Notification Of Notice Of Publication E-Mailed

Oct 28, 2022

New Representative At Ib Received

Oct 17, 2022

Approved For Pub - Principal Register

Jul 25, 2022

Examiner's Amendment Entered

Jul 25, 2022

Notification Of Examiners Amendment E-Mailed

Jul 25, 2022

Examiners Amendment E-Mailed

Jul 25, 2022

Examiners Amendment -Written

May 31, 2022

Teas/Email Correspondence Entered

May 31, 2022

Correspondence Received In Law Office

May 31, 2022

Teas Response To Office Action Received

Apr 11, 2022

Refusal Processed By Ib

Mar 18, 2022

Non-Final Action Mailed - Refusal Sent To Ib

Mar 18, 2022

Refusal Processed By Mpu

Feb 17, 2022

Non-Final Action (Ib Refusal) Prepared For Review

Feb 16, 2022

Non-Final Action Written

Feb 7, 2022

Assigned To Examiner

Dec 11, 2021

Change Of Name/Address Rec'd From Ib

Oct 16, 2021

Application Filing Receipt Mailed

Oct 12, 2021

New Application Office Supplied Data Entered

Oct 8, 2021

Sn Assigned For Sect 66a Appl From Ib